Inhalation And Nasal Product Development
From ab initio development to proof of concept, i2C supports every aspect of inhaled product development—including pMDIs, DPIs, nebulisers, and nasal sprays—tailoring each formulation to your molecule, device, and target patient profile.
Our Capabilities
Integrated Device & Formulation Expertise
Our team brings deep device knowledge, ensuring your formulation and inhaler work together for optimal drug delivery and patient usability.
Innovative Technologies
i2C offers proprietary platforms like Respitab®, a propellant-dispersible tablet technology that streamlines the formulation and scale-up of next-generation pMDIs—making development faster, simpler, and more cost-effective.
Flexible, Client-Focused Approach
Whether you need early proof-of-concept support, reformulation, or scale-up for clinical trials, i2C’s agile team delivers tailored solutions that reduce time to market and development risk.
Comprehensive Dosage Form Support
Our expertise spans powders, solutions, and suspensions for inhaled delivery, ensuring the right formulation for your product’s unique requirements.
Analytical Method Development:
We develop and optimise analytical methods tailored to your product requirements, ensuring smooth progression from early development to proof of concept.
Clinical & In Vivo Support
Our integrated services include bespoke gamma scintigraphy imaging studies to evaluate in vivo deposition, residence, and clearance—providing robust data for regulatory submissions and clinical success.
Why Partner with i2C?
Decades of inhalation formulation experience and a track record with 50+ pharma clients 
Independent, state-of-the-art facilities in Cardiff, Wales
Rapid, cost-effective R&D programs that accelerate your route to clinic
End-to-end project management and seamless integration with analytical and manufacturing services